AI startups are seeing record valuations, but many are building on a foundation of cheap, free-to-download Chinese AI models.

The round includes prior lead investors Sequoia Capital, Lightspeed Venture Partners, Greenoaks, and BOND, with participation ...

The Trade Desk, Inc. is rated a Buy emphasizing visible margin recovery and compelling rebound potential for 2025. Read more ...

Triana Biomedicines has tapped Pfizer Ventures and a number of other existing and new investors to secure a $120 million ...

USA-based TRIANA Biomedicines has announced the successful closing of its oversubscribed $120 million Series B financing round.

TRIANA Biomedicines announces $120M Series B financing to advance its molecular glue degrader pipeline and TRI-611 to clinical proof of concept.

Protego Biopharma is gearing up to bring its amyloid light-chain (AL) amyloidosis prospect into pivotal testing using its new ...

The company detailed today that prominent tech investor Elad Gill led the Series D raise. He was joined by Sequoia Capital, ...

The moves come on the back of a larger restructuring plan as Udaan looks to streamline costs, reduce burn and improve unit ...

Lightspeed Venture Partners, a leading Silicon Valley-based investment firm, is of the view that despite the current valuation "euphoria" in artificial intelligence (AI), the technology represents a ...

Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.

Pacific's leading multi-currency travel card, expects to maintain annual growth of 10% over the next three years and is ...